John Wiley & Sons

SHERPA: Green

People

  1. Breitbart
    Breitbart
  2. Nelson
    Nelson
  3. Busam
    Busam
  4. Applebaum
    Applebaum
  5. Roth
    Roth
  6. Zelenetz
    Zelenetz
  7. Ostroff
    Ostroff
  8. Rossi
    Rossi
  9. Begg
    Begg
  10. Gany
    Gany

Groups

  1. Department of Medicine (566)
  2. Population Sciences Research Program (528)
  3. Psychiatry and Behavioral Sciences, Department of (459)
  4. Psychiatry Service (327)
  5. Survivorship Research (321)
  6. Center for Hematologic Malignancies (285)
  7. Hematologic Malignancies, Division of (259)
  8. GSK Faculty (254)
  9. Sloan Kettering Institute Faculty (246)
  10. Surgery (212)
Search Within
Formats
  1. Journal Article (1356)
  2. Meeting Abstract (727)
  3. Conference Paper (111)
  4. Book Section (53)
  5. Review (44)
  6. Editorial (24)
  7. Research Letter (14)
  8. Correspondence (9)
  9. Book Whole (4)
  10. Guidelines (2)
  11. Miscellaneous (2)
Groups
  1. Department of Medicine (566)
  2. Population Sciences Research Program (528)
  3. Psychiatry and Behavioral Sciences, Department of (459)
  4. Psychiatry Service (327)
  5. Survivorship Research (321)
  6. Center for Hematologic Malignancies (285)

More Groups

People
  1. William Breitbart (88)
  2. Christian Nelson (87)
  3. Jimmie Holland (75)
  4. Klaus Busam (56)
  5. Allison Applebaum (44)
  6. Lloyd Old (41)

More People

Years
  1. 2025 (54)
  2. 2024 (77)
  3. 2023 (106)
  4. 2022 (85)
  5. 2021 (90)
  6. 2020 (102)

More Years

Publications
  1. Psycho-Oncology (630)
  2. British Journal of Haematology (267)
  3. International Journal of Cancer (267)
  4. Journal of Cellular Biochemistry (178)
  5. Annals of the New York Academy of Sciences (112)
  6. Journal of Cutaneous Pathology (90)

More Publications

Results (2346)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pirtobrutinib, a highly selective, non-covalent BTK inhibitor in Richter transformation: Results from the BRUIN study
    Meeting Abstract

    Lewis, D. J.; Wierda, W. G.; Ghia, P.; Shah, N. N.; Coombs, C. C.; Cheah, C. Y.; Lamanna, N.; Rhodes, J. M.; Hoffmann, M. S.; Ma, S.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Pirtobrutinib efficacy in covalent BTK-inhibitor pre-treated relapsed/refractory mantle cell lymphoma: Extended follow-up from BRUIN
    Meeting Abstract

    Lewis, D. J.; Wang, M. L.; Shah, N. N.; Jurczak, W.; Zinzani, P. L.; Eyre, T. A.; Cheah, C. Y.; Ujjani, C. S.; Koh, Y.; Izutzu, K.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial
    Meeting Abstract

    Ramasamy, K.; Nooka, A.; Cohen, A.; Lee, H.; Badros, A.; Suvannasankha, A.; Callander, N.; Abdallah, A. O.; Trudel, S.; Chari, A.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Efficacy of subcutaneous epcoritamab versus chemoimmunotherapy and axi-cel in R/R LBCL: An indirect comparison
    Meeting Abstract

    Alshreef, A.; Wang, A.; Mutebi, A.; Davies, K.; van de Wetering, G.; Chirikov, V.; Salles, G.
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Real-world transfusion independence among newly diagnosed acute myeloid leukaemia patients receiving venetoclax combinations versus other therapies
    Meeting Abstract

    Wolach, O.; Garcia, J.; Vachhani, P.; Zeidner, J.; Lai, C.; Moshe, Y.; Xavier, M.; Lee, S.; Zuckerman, T.; Pollyea, D.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Outcomes in B-cell precursor acute lymphoblastic leukaemia patients receiving inotuzumab ozogamicin prehaematopoietic stem cell transplantation
    Meeting Abstract

    Marks, D.; de Lima, M.; Kebriaei, P.; Lanza, F.; Cho, C.; Popradi, G.; Zhang, M. J.; Zhang, F.; Welch, V.; Tikka, S.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Daratumumab plus Lenalidomide/dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: MAIA update
    Meeting Abstract

    Basu, S.; Kumar, S. K.; Moreau, P.; Bahlis, N.; Facon, T.; Plesner, T.; Orlowski, R. Z.; Nahi, H.; Hulin, C.; Quach, H.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma: Cohort a of MagnetisMM-3
    Meeting Abstract

    Shay, G.; Bahlis, N.; Tomasson, M. H.; Mohty, M.; Niesvizky, R.; Nooka, A.; Manier, S.; Maisel, C.; Jethava, Y.; Martinez-Lopez, J.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Pirtobrutinib monotherapy in patients with relapsed/refractory B-cell malignancies intolerant to prior covalent BTK inhibitor
    Meeting Abstract

    Munir, T.; Shah, N. N.; Wang, M.; Brown, J. R.; Patel, K.; Woyach, J.; Wierda, W. G.; Ujjani, C. S.; Eyre, T. A.; Zinzani, P. L.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • In vivo reflectance confocal microscopy criteria to monitor treatment response for biopsy- proven basal cell carcinoma
    Meeting Abstract

    Kohli, I.; Wuennenberg, J.; Jones, B.; Jain, M.; Grant-Kels, J.; Ozog, D.
    Lasers in Surgery and Medicine (2023)

    Fulltext@MSK | Save